Sign up to save your podcasts
Or
Share Looking Ahead in Complement-Mediated Kidney Diseases: What Clinical Questions Do Current Trials Aim to Answer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Looking Ahead in Complement-Mediated Kidney Diseases: What Clinical Questions Do Current Trials Aim to Answer
Did you know that, if left untreated, between 30% and 50% and up to 30% of patients with C3G and IgAN, respectively, will progress to end-stage kidney disease in 10 years? Credit available for this activity expires: 5/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992405?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.3
2525 ratings
Did you know that, if left untreated, between 30% and 50% and up to 30% of patients with C3G and IgAN, respectively, will progress to end-stage kidney disease in 10 years? Credit available for this activity expires: 5/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992405?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
JAMA Editors' Summary
135 Listeners
AFP: American Family Physician Podcast
695 Listeners
JAMA Clinical Reviews
499 Listeners
JACC This Week
166 Listeners
Diabetes Core Update
105 Listeners
This Week in Cardiology
886 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
301 Listeners
Frankly Speaking About Family Medicine
263 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
Core IM | Internal Medicine Podcast
1,142 Listeners
Annals On Call Podcast
198 Listeners
JAMA Medical News
91 Listeners
The Clinical Problem Solvers
516 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Freely Filtered, a NephJC Podcast
169 Listeners
Medicine and the Machine
61 Listeners
Keeping Current
9 Listeners
Cardionerds: A Cardiology Podcast
427 Listeners